http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002106770-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2001-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae4b8974aafe1772b35e86bd15225946 |
| publicationDate | 2002-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002106770-A1 |
| titleOfInvention | 25233, a novel human aminotransferase and uses therefor |
| abstract | The invention provides isolated nucleic acids molecules, designated 25233 nucleic acid molecules, which encode novel aminotransferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 25233 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 25233 gene has been introduced or disrupted. The invention still further provides isolated 25233 proteins, fusion proteins, antigenic peptides and anti-25233 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2000-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1766.